CorMedix (CRMD) Change in Acquisitions & Divestments (2015 - 2025)
CorMedix (CRMD) reported Change in Acquisitions & Divestments of $3.6 million for Q4 2025, down 27.99% on a YoY basis from $5.0 million in Q4 2024, and down 89.35% sequentially from $33.8 million in Q3 2025.
CorMedix (CRMD) Change in Acquisitions & Divestments (2015 - 2025) Analysis & Trends
CorMedix (CRMD) has 11 years of Change in Acquisitions & Divestments data on file, last reported at $3.6 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 27.99% year-over-year to $3.6 million; the trailing twelve-month figure through Dec 2025 stood at $55.3 million (up 14.92% YoY), and the FY2025 full-year result was $55.3 million, up 14.92% from the prior year.
- Change in Acquisitions & Divestments eased to $3.6 million in Q4 2025, from $33.8 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $33.8 million in Q3 2025 to a low of $13.0 in Q4 2021.
- A 5-year average of $9.9 million and a median of $8.1 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments tumbled 100.0% in 2021 and soared 68461438.46% in 2022, its largest moves.
- Tracing CRMD's Change in Acquisitions & Divestments over 5 years: stood at $13.0 in 2021, then soared by 68461438.46% to $8.9 million in 2022, then soared by 91.01% to $17.0 million in 2023, then slumped by 70.59% to $5.0 million in 2024, then decreased by 27.99% to $3.6 million in 2025.
- Business Quant data shows CRMD's Change in Acquisitions & Divestments at $3.6 million in Q4 2025, $33.8 million in Q3 2025, and $8.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn |
| 10 | CorMedix | 4.97 Mn | -150.23 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.60 Mn |
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 33.79 Mn |
| Sep 30, 2025 | 33.79 Mn |
| Jun 30, 2025 | 8.10 Mn |
| Jun 30, 2025 | 8.10 Mn |
| Mar 31, 2025 | 9.80 Mn |
| Mar 31, 2025 | 9.80 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 18.42 Mn |
| Jun 30, 2024 | 18.42 Mn |
| Mar 31, 2024 | 16.70 Mn |
| Mar 31, 2024 | 16.70 Mn |
| Dec 31, 2023 | 17.00 Mn |
| Dec 31, 2023 | 17.00 Mn |
| Sep 30, 2023 | 17.50 Mn |
| Sep 30, 2023 | 17.50 Mn |